Asset Details
Do you wish to reserve the book?
Racial differences in inflammation and outcomes of aging among kidney transplant candidates
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Racial differences in inflammation and outcomes of aging among kidney transplant candidates
Do you wish to request the book?
Racial differences in inflammation and outcomes of aging among kidney transplant candidates
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Racial differences in inflammation and outcomes of aging among kidney transplant candidates
2019
Overview
Background
Inflammation is more common among African Americans (AAs), and it is associated with frailty, poor physical performance, and mortality in community-dwelling older adults. Given the elevated inflammation levels among end-stage renal disease (ESRD) patients, inflammation may be associated with adverse health outcomes such as frailty, physical impairment, and poor health-related quality of life (HRQOL), and these associations may differ between AA and non-AA ESRD patients.
Methods
One thousand three ESRD participants were recruited at kidney transplant evaluation (4/2014–5/2017), and inflammatory markers (interleukin-6 [IL-6], tumor necrosis factor-a receptor-1 [TNFR1], C-reactive protein [CRP]) were measured. We quantified the association with frailty (Fried phenotype), physical impairment (Short Physical Performance Battery [SPPB]), and fair/poor HRQOL at evaluation using adjusted modified Poisson regression and tested whether these associations differed by race (AA vs. non-AA).
Results
Non-AAs had lower levels of TNFR1 (9.7 ng/ml vs 14.0 ng/ml,
p
< 0.001) and inflammatory index (6.7 vs 6.8,
p
< 0.001) compared to AAs, but similar levels of IL-6 (4.5 pg/ml vs 4.3 pg/ml,
p
> 0.9) and CRP (4.7 μg/ml vs 4.9 μg/ml,
p
= 0.4). Non-AAs had an increased risk of frailty with elevated IL-6 (RR = 1.58, 95% CI:1.27–1.96,
p
< 0.001), TNFR1 (RR = 1.60, 95% CI:1.25–2.05,
p
< 0.001), CRP (RR = 1.41, 95% CI:1.10–1.82,
p
< 0.01), and inflammatory index (RR = 1.82, 95% CI:1.44–2.31,
p
< 0.001). The associations between elevated inflammatory markers and frailty were not present among AAs. Similar results were seen with SPPB impairment and poor/fair HRQOL.
Conclusions
Non-AAs with elevated inflammatory markers may need closer follow-up and may benefit from prehabilitation to improve physical function, reduce frailty burden, and improve quality of life prior to transplant.
